Author/Authors :
Dmitriy Minond، نويسنده , , S. Adrian Saldanha، نويسنده , , Prem Subramaniam، نويسنده , , Michael Spaargaren، نويسنده , , Timothy Spicer، نويسنده , , Joseph R. Fotsing، نويسنده , , Timo Weide، نويسنده , , Valery V. Fokin، نويسنده , , K. Barry Sharpless، نويسنده , , Moreno Galleni، نويسنده , , Carine Bebrone، نويسنده , , Patricia Lassaux، نويسنده , , Peter Hodder، نويسنده ,
Abstract :
VIM-2 is an Ambler class B metallo-β-lactamase (MBL) capable of hydrolyzing a broad-spectrum of β-lactam antibiotics. Although the discovery and development of MBL inhibitors continue to be an area of active research, an array of potent, small molecule inhibitors is yet to be fully characterized for VIM-2. In the presented research, a compound library screening approach was used to identify and characterize VIM-2 inhibitors from a library of pharmacologically active compounds as well as a focused ‘click’ chemistry library. The four most potent VIM-2 inhibitors resulting from a VIM-2 screen were characterized by kinetic studies in order to determine Ki and mechanism of enzyme inhibition. As a result, two previously described pharmacologic agents, mitoxantrone (1,4-dihydroxy-5,8-bis([2-([2-hydroxyethyl]amino)ethyl]amino)-9,10-anthracenedi